检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

744 Interim single-agent safety and anti-tumor activity from dose escalation phase of ABILITY study on MDNA11, a long-acting beta-only IL-2 agonist

Minh To,Fahar Merchant,Victoria Atkinson,Martin Bexon, Jim Coward,Jenny Lee,Charlotte Lemech,Jesus Antras,Peter Lloyd,Arash Yavari,Melissa Coello,Nina Merchant

Regular and Young Investigator Award Abstracts（2022）

引用 0|浏览2
暂无评分
关键词
dose escalation phase,agonist,single-agent,anti-tumor,long-acting,beta-only
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要